| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |